PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GxP Ltd

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Quotient Bioresearch Deploys GxPi’s X-docs™ ‘Server’ EDMS to Manage Vital Documents - Quotient Bioresearch deploys GxPi’s x-docs™ ‘Server’ EDMS to manage vital documents for the drug development process
Quotient Bioresearch Deploys GxPi’s X-docs™ ‘Server’ EDMS to Manage Vital Documents


NewswireToday - /newswire/ - Nottingham, Nottinghamshire, United Kingdom, 2011/02/28 - Quotient Bioresearch deploys GxPi’s x-docs™ ‘Server’ EDMS to manage vital documents for the drug development process.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


GxPi, specialists in providing compliant IT solutions to the Life Sciences sector, announced today that their x-docs™ ‘Server’ electronic document management solution (EDMS) has been successfully installed and implemented by Quotient Bioresearch across 4 sites in the UK.

x-docs™ allows Quotient to manage their controlled documents on a Microsoft SharePoint platform. It has been configured to their specific controlled document needs and is now being rolled out to over 400 users.

Quotient ( is a leading provider of early stage and specialist drug development services to pharmaceutical, biotechnology and medical device clients worldwide. Their services are regulated under GCP, GLP and GMP regulations by the MHRA.

They acquired x-docs™ to enable secure sharing of controlled documents in a secure environment across multiple locations, but they also wanted a Validated product that conformed to the FDA’s 21CFR Part 11 requirements on Electronic Records and Electronic Signatures. This meant compliant audit history, security access, and operational features such as document specific auto-numbering, configured document lifecycle and integrated change request processes.

Standard Operating Procedures (SOPs) are essential documents in Life Sciences businesses and are used to ensure that all quality processes and procedures are carried out in a consistent and compliant manner. SOPs need to be securely stored and tracked throughout their entire life-cycle, including when they are superseded and withdrawn in order to comply with Part 11 electronic records management. This continues into the support for the storage of these ‘archived versions’. They decided to use MS SharePoint as their platform as their existing systems did not support the group-wide services they needed. GxPi has developed an SOP module on x-docs™ to streamline and standardise the creation, review, approval, publishing and distribution of SOPs in a fully Electronic Document Management System (EDMS).

x-docs™ ensures compliance with FDA 21 CFR part 11 guidelines by storing the full audit history for each document, allowing electronic signatures to be stored with the document during approval stage. There is also a centralised PDF rendering tool, which saves the user time by allowing the creation of high-quality, FDA-compliant PDFs as part of the publishing process. Other additional functions suited for the needs of the Life Sciences industry include:

• Configurable Document Lifecycle and workflow based state transition;
• Approval workflows with user authentication (enables Part 11 compliant eSignature);
• Configurable Approval groups;
• Read & Understood Distribution – groups configurable at point of dispatch;
• PDF published approved versions for content consumers to access;
• Configurable AutoNumber function;
• Automated document Effectivity function;
• Periodic Review functionality;
• InfoPath forms based Document Change process;
• Automated sitebuilder and configuration tools to enable the creation and rapid validation of complex storage structures;
• InfoPath forms based CAPA module.

x-docs™ was a great help when, earlier in 2010, Quotient acquired a new business with many existing documents, and they were able to migrate the existing documents straight on to the new system making for a hassle free changeover. Quotient were using the hosted version of the x-docs™ product at the time which means that their documents are held on GxPi’s secure servers in their validated data centre. The system was taken in house on Quotient’s servers in November.

The Quality Manager at Quotient comments that “We chose GxPi and x-docs™ because the team seemed to understand a lot of our problems with controlled documents, particularly where we had documents that were going to be shared across multiple sites and access would be based on permissions. We really liked the simple user interface and the integration with our existing working tools. We were able to talk to some of their other customers who had employed x-docs™, and we looked hard at their processes and systems and were very satisfied by what we found”.

The Group ICT Manager commented “We had already established that SharePoint was going to be our platform and, after talking with GxPi, we realised that they not only had the skills to deliver the compliance aspects of the document management system, but as Microsoft Gold Partners, they had the technical skills to configure our build. We knew we wanted some new code functions and features building, and also some specialised webparts and they were able to quickly understand what we wanted and why.

They had developed some useful tools to deploy, build, assign permissions and test quite a complicated site hierarchy. We were also pleased to see that they had other solutions on SharePoint for compliant training management and Digital Signatures that we could integrate at a later stage.”

Keith Williams, CEO, GxPi comments: “We are really pleased that this project has been such a success. When we started the process, we spent time educating the Quotient team around what was possible with SharePoint and x-docs™, establishing and capturing their baseline requirements, and setting up a test area for them to work in.

We then built a detailed design specification and configuration specification with them and helped bring one of their sites on-line sooner than expected to migrate their documents following an acquisition. After the build and testing we trained the key User group and administrators and delivered a User manual specific for their system. Most of the time both project teams worked in a very constructive and collaborative way, and this has made it a pleasurable experience right the way through the process.”

For more information about Quotient Bioresearch, please call +44 (0) 1638 720 500, or email info[.] Alternatively please visit

About GxPi
GxPi ( provides Simply Compliant Services and Solutions to the Life Science and Regulated Industries.
GxPi Services delivers high quality, results-focussed GxP consultancy services within the following areas:

• Regulatory compliance;
• Strategic Quality consulting;
• Computer system validation;
• Qualified Person Services;
• Training.

This success is demonstrated through repeat business with existing clients and an ever-increasing number of new clients.

GxPi Solutions have developed x-docs™; a simple, cost effective product for EDMS.
x-docs™ offers significant cost benefits and because the core is SharePoint, high flexibility.
Optional functional modules developed on x-docs™ include:

• SOPs
• eTMF
• Due Diligence
• x-train™

x-docs™ is delivered Out Of the Box (OOB) or Configured to your own needs either as an internal Server deployed or compliant Hosted solution.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: GxP Ltd


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

Quotient Bioresearch Deploys GxPi’s X-docs™ ‘Server’ EDMS to Manage Vital Documents

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Keith Williams - 
+44(0)11 5924 8477 info[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GxP Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From GxP Ltd / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.

  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (